文献
J-GLOBAL ID:201802223580089121
整理番号:18A1382568
自己免疫疾患におけるヒトジヒドロオロット酸デヒドロゲナーゼ(HDHODH)阻害剤の使用と癌治療における新たな展望【JST・京大機械翻訳】
Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy
著者 (6件):
Lolli Marco L.
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
,
Sainas Stefano
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
,
Pippione Agnese C.
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
,
Giorgis Marta
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
,
Boschi Donatella
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
,
Dosio Franco
(Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy)
資料名:
Recent Patents on Anti-Cancer Drug Discovery
(Recent Patents on Anti-Cancer Drug Discovery)
巻:
13
号:
1
ページ:
86-105
発行年:
2018年
JST資料番号:
W3649A
ISSN:
1574-8928
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
不明 (ARE)
言語:
英語 (EN)